Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer’s Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study Authors: Yu-Ting Wei, Li Li, Wen-Ting Xie, Yan Wang, Ya-Ru Zhao, Ren-Zhen Zhang, Ling Ma, Xing-Ke Yan Published: 2026 ABSTRACT AbstractPurposeAlzheimer’s disease (AD) is increasingly prevalent, yet how acupuncture modulates cognitive brain networks remains unclear. We used resting-state fMRI (rs-fMRI) to examine whether acupuncture prescription regulates effective connectivity within the frontoparietal network (FPN) in AD.Patients and MethodsSixty AD patients were randomized to donepezil alone (drug group) or acupuncture plus donepezil (acupuncture group) for 6 weeks (n=30/group). Seven healthy controls were scanned once. Global cognition was assessed with MoCA-B. Independent component analysis identified the FPN, and Granger causality analysis quantified directed effective connectivity before and after treatment.ResultsBoth interventions improved MoCA-B (P<0.05), with larger gains in the acupuncture group (P<0.05). Relative to controls, AD showed FPN disruption with compensatory reorganization. Decreased connectivity was observed from the left middle temporal gyrus (MTG) to the right inferior parietal lobule (IPL), and from the left median cingulate/paracingulate gyri (P<0.05). Increased connectivity emerged from the right IPL and left cingulate/paracingulate to the left MTG, and from the right IPL to the left medial frontal gyrus (orbital part) (P<0.05). The right IPL and left MTG were core FPN nodes. Post-treatment, the drug group showed reduced right IPL→left orbital medial frontal connectivity, whereas the acupuncture group showed reduced right IPL→left MTG connectivity (P<0.05). Between-group comparisons indicated acupuncture-specific modulation of right insula→left MTG and left precuneus→left MTG connectivity (P<0.05).ConclusionAcupuncture combined with donepezil provides superior cognitive benefits and selectively reshapes directed FPN interactions, supporting a network-level mechanism involving frontal–parietal–temporal integration.Keywords: Alzheimer’s disease, acupuncture, resting-state functional magnetic resonance imaging, frontoparietal network, effective connectivity Introduction Alzheimer’s disease (AD) is a common neurodegenerative disorder in older adults.1 Clinically, it is characterized by progressive cognitive decline, impaired activities of daily living, and behavioral and psychological disturbances.2 Epidemiological studies indicate a strong association between AD onset and aging: the prevalence of AD is approximately 10% among individuals aged 65–75 years and increases to 32% in those over 80 years.3 As of 2018, the number of people living with AD worldwide had reached nearly 50 million.4–6 The continuous progression of AD compromises functional independence in older adults, leading to substantial impairment in self-care abilities and imposing a heavy economic burden on families and society. Consequently, AD has become a major public health challenge requiring urgent attention.7,8 Current therapeutic approaches for AD include pharmacological treatment,9 cognitive stimulation therapy,10,11 and neuromodulation-based interventions.12,13 Although these approaches can partially improve cognitive function, their limitations—such as adverse effects and the need for long-term administration—remain significant. In contrast, acupuncture is considered particularly effective for disorders related to cognitive dysfunction. Clinical and experimental evidence has shown that acupuncture produces notable therapeutic benefits in AD, offering advantages such as high patient adherence, good tolerability, and minimal side effects.14 Moreover, the cognitive-enhancing effects of acupuncture in AD have been linked to multiple molecular mechanisms, such as regulating Aβ and tau protein expression, suppressing central inflammatory responses and oxidative stress, improving regional brain energy metabolism, enhancing synaptic plasticity, and modulating autophagy and neuronal apoptosis.15 Neuroimaging studies have revealed that multiple spatially distinct brain regions exhibit temporally synchronized low-frequency oscillations during rest, cooperating to regulate specific functional processes. These interconnected regions collectively form intrinsic functional brain networks.16 Current research demonstrates that several cognitive domains impaired in AD—including episodic memory, executive function, attention, visuospatial orientation, and language—are regulated by key networks such as the default mode network (DMN), frontoparietal network (FPN), and attention network (AN).17 Among these, the FPN serves as a central regulatory hub, dynamically integrating task demands and expected outcomes. It flexibly couples with task-related networks and modulates patterns and strengths of functional connectivity to support cognitive control.18 Thus, we hypothesize that the FPN is a core network affected in AD and that its dysfunction is closely associated with disease progression. Resting-state functional magnetic resonance imaging (rs-fMRI), based on the blood oxygen level-dependent (BOLD) mechanism of neurovascular coupling,19,20 enables the monitoring of hemodynamic fluctuations associated with spontaneous neuronal activity and thereby provides an indirect but powerful method for assessing intrinsic brain function.21 This technology offers valuable support for investigating the neural mechanisms underlying cognitive, behavioral, and psychological impairments in AD, as well as for elucidating the brain mechanisms of acupuncture. Granger causality analysis (GCA), which assesses directional causal relationships among rs-fMRI time series, allows the evaluation of cooperative interactions among different brain regions or networks and tracks the directional flow of information between them. As such, GCA is an effective tool for characterizing effective connectivity and understanding patterns of directional network interactions.22 However, few studies have examined whether acupuncture can modulate abnormal causal interactions within the FPN in AD. Therefore, in this study, we extracted the component regions of the FPN using independent component analysis (ICA) and applied bivariate granger causality modeling to assess causal relationships within the FPN in AD patients. We first compared effective connectivity patterns between AD patients (AD group) and healthy controls (HC group); subsequently, we analyzed the effects of donepezil hydrochloride and acupuncture on FPN effective connectivity in AD. Materials and Methods Study Design and Participants This randomized controlled study was approved by the ethics committee of the Affiliated Hospital of Gansu University of Chinese Medicine (Approval No. [2022] 12). The study protocol was registered with the Chinese Clinical Trial Registry (ChiCTR2200056137) and conducted in accordance with the principles of the Declaration of Helsinki. All participants were fully informed of the study details, provided their voluntary consent to participate in this trial, and signed an informed consent form, which explicitly stated that they might undergo rs-fMRI scans. A total of 67 individuals were recruited between July 2021 and October 2022 from the Affiliated Hospital of Gansu University of Chinese Medicine, as well as through community advertisements (Before January 6, 2022, only basic information of potential participants who expressed willingness to participate was recorded; these individuals were not formally enrolled in the study. The present study officially commenced only after approval was obtained from the Ethics Committee). The sample consisted of 60 patients with AD (AD group) and 7 healthy controls (HC group) matched for age, gender, and educational level. The 60 AD patients were randomly assigned to either the drug group or the acupuncture group (30 participants in each group) using random numbers generated by SPSS version 26. During the clinical evaluation phase, 2 participants in the drug group were excluded due to adverse drug reactions, and 3 participants in the acupuncture group were excluded due to intolerance to treatment. For the neuroimaging component, among the volunteers who met the criteria for fMRI scanning, 15 participants were randomly selected for the scan using a computer-generated randomization sequence created with SPSS version 26. During data preprocessing, datasets were excluded if head motion exceeded 3 mm of translation or 3° of rotation, or if scan coverage was inadequate.23–25 As a result, 3 participants in the drug group were excluded, yielding 12 valid datasets; in the acupuncture group, 4 participants were excluded, yielding 11 valid datasets. Although 10 healthy controls were initially planned, only 7 were successfully recruited; after excluding 1 participant for excessive head motion, 6 valid control datasets remained for analysis (Figure 1). Flowchart of the trial. Note: A total of 67 participants were assessed for eligibility, including 60 patients with Alzheimer’s disease (AD) and 7 healthy controls (HC). AD patients were randomized into the Drug group (η=30) and the Acupuncture group (η=30). For clinical efficacy, 28 patients in the Drug group and 27 in the Acupuncture group were included in the final analysis.For the resting-state fMRI (rs-fMRI) study, 15 patients from each group and 7 healthy controls were enrolled for scanning. After excluding data due to quality control, the final neuroimaging analyses included 12 patients in the Drug group, 11 in the Acupuncture group, and 6 HCs. Inclusion and Exclusion Criteria Inclusion criteria were as follows: 1) participants of any gender, right-handed, aged 50–90 years; 2) patients in the medication or acupuncture group met the diagnostic criteria outlined in the 2018 Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Impairment (II): Guidelines for the Diagnosis and Treatment of AD;26 3) no acupuncture treatment within the previous six months; 4) the patient or their legal guardian voluntarily agreed to participate and provided written informed consent. Exclusion criteria were as follows: 1) Patients with severe organic diseases of the heart, liver, or kidneys confirmed by imaging examinations such as ultrasound, CT, or MRI (eg., liver cirrhosis, renal failure, heart failure, etc).; patients with mental disorders including depression, anxiety disorder, schizophrenia, etc., definitely diagnosed by psychiatrists; 2) Patients with neurological disorders that may affect brain function and cognitive function were excluded, such as Parkinson’s disease, cerebral infarction, cerebral hemorrhage, epilepsy, intracranial space-occupying lesions, and severe traumatic brain injury.3) severe visual or hearing impairment that interfered with completion of the assessments; 4) intolerance to donepezil hydrochloride or acupuncture treatment; 5) Patients who had received medications affecting cerebral metabolism, cerebral blood flow, and central nervous system function within the past 1 month were excluded. 6) participation in other clinical trials concurrently; 7) contraindications to MRI examination. Treatment Regimen Drug Group Participants in the drug group received oral donepezil hydrochloride tablets (Eisai China Inc.; approval No. H20050978; 5 mg/tablet). The medication was administered once daily at a dose of 5 mg before bedtime. After 4 consecutive weeks, the dose was increased to 10 mg, with a total treatment duration of 6 weeks. Acupuncture Group On the basis of the same pharmacological treatment used in the drug group, participants in the acupuncture group received acupuncture according to the “Yizhi Tiaoshen” prescription (Figure 2). The selected acupoints were Baihui (GV20), Sishencong (EX-HN1), Shenmen (HT7), Neiguan (PC6), Zusanli (ST36), Sanyinjiao (SP6), and Xuanzhong (GB39), with localization based on the national standard Nomenclature and Location of Acupuncture Points (GB/T 12346–2006).27 Acupoints for the acupuncture group. Note: The schematic illustrates the specific acupoints selected for the “ Yizhi Tiaoshen” prescription. The locations include Baihui (GV20) and Sishencong (EX-HN1) on the head; Neiguan (PC6) and Shenmen (HT7) on the upper limb; and Zusanli (ST36), Xuanzhong (GB39), and Sanyinjiao (SP6) on the lower limb. Disposable sterile filiform needles (Huacheng brand; 0.30×25 mm or 0.30×40 mm; Beijing Medical Device Registration No. 20182271110) were used. The needling depths were as follows: Baihui, transverse insertion 13–20 mm; Sishencong, transverse insertion toward Baihui 13–20 mm; Shenmen, perpendicular insertion 8–13 mm; Neiguan, perpendicular insertion 13–24 mm; Zusanli and Sanyinjiao, perpendicular insertion 25–38 mm; and Xuanzhong, perpendicular insertion 13–20 mm. After achieving deqi (arrival of qi), the first four acupoints were manipulated with a mild reinforcing–reducing technique, while the remaining three acupoints were stimulated using lifting and thrusting and rotating reinforcement for approximately 1 minute. Needles were retained for 30 minutes, with additional manipulation performed once at the 15-minute mark. Treatments were administered once daily, six times per week, for a total of 6 weeks. Clinical Evaluation Scale Both groups underwent the following assessments before and after treatment. All scales and neuropsychological evaluations were administered by a qualified neuropsychologist who was blinded to group allocation. Montreal Cognitive Assessment–Basic, Chinese Version (MoCA-B) The MoCA-B consists of 10 subdomains assessing executive function, verbal fluency, orientation, calculation, abstraction, delayed recall, visuoperceptual ability, naming, and attention. The total score is 30 points. Based on years of education, the cutoff values for cognitive impairment are ≤19 for individuals with ≤6 years of education, ≤22 for those with 7–12 years of education, and ≤24 for those with more than 12 years of education. Lower scores reflect more severe cognitive dysfunction.28 Rs-fMRI Scanning Protocol Healthy controls underwent a single rs-fMRI scan, whereas patients in both groups received rs-fMRI scans before and after treatment. All imaging was performed using a 3.0-T MRI scanner (Ingenia Elition X, Philips Healthcare, The Netherlands) equipped with a 32-channel phased-array head coil and high-attenuation noise-reduction earplugs. Upon entering the scanner room, participants were positioned supine with their heads secured using a fitted head holder to minimize voluntary and involuntary movements. Earplugs were provided to reduce external noise interference. Participants were instructed to remain awake, keep their eyes closed, breathe steadily, and avoid engaging in any deliberate cognitive activity during the scan. The scanning procedure included a 2-min 38-s high-resolution three-dimensional T1-weighted structural scan followed by an 8-min 6-s resting-state fMRI acquisition. After confirming the absence of gross abnormalities such as hemorrhage or tumors on routine imaging, structural images were acquired using a fast field echo (FFE) gradient-echo sequence with the following parameters: repetition time (TR) = 6.6 ms; echo time (TE) = 3 ms; flip angle = 8°; voxel size = 1 mm × 1 mm × 1 mm; field of view (FOV) = 240 mm × 240 mm; slice thickness = 1 mm; no interslice gap; 170 slices in total. Resting-state functional images were acquired using an axial echo-planar imaging (EPI) sequence with the following parameters: TR = 2000 ms; TE = 30 ms; flip angle = 90°; voxel size = 2 mm × 2 mm × 2 mm; FOV = 224 mm × 224 mm; slice thickness = 2 mm; 42 slices; and 240 whole-brain volumes collected. Data Processing of Rs-fMRI Rs-fMRI data were preprocessed and analyzed using the RESTplus V1.27 toolbox running on Statistical Parametric Mapping (SPM12) within the MATLAB 2017b environment. The preprocessing steps included the following: (1) Format conversion and discarding initial volumes: Raw data were converted from DICOM to NIFTI format using MRIcronGL. The first 10 time points were removed to eliminate signal instability and to minimize fluctuations caused by participant adaptation at the beginning of the scan. (2) Slice-timing correction: In this study, rs-fMRI data were acquired from the vertex to the base of the skull using an interleaved odd–even scanning order ([41:-2:1; 42:-2:2]). Slice-timing correction was applied to compensate for temporal differences in slice acquisition. (3) Head-motion correction: Participants with head movement exceeding 3.0 mm of translation or 3.0° of rotation were excluded. (4) Spatial normalization: The new_segment algorithm was used to first coregister T1-weighted structural images to the rs-fMRI images. T1 images were then segmented into gray matter, white matter, cerebrospinal fluid, skull, soft tissue, and meninges. The segmented images were resampled to 3 mm × 3 mm × 3 mm voxels and normalized to the Montreal Neurological Institute (MNI) standard space. (5) Spatial smoothing: A Gaussian kernel with 6 mm full width at half maximum (FWHM) was applied to the normalized images to improve the signal-to-noise ratio. (6) Nuisance regression: Friston-24 head-motion parameters, cerebrospinal fluid signals, and white matter signals were regressed out to reduce physiological and movement-related confounds. (7) Detrending: Linear detrending was performed to remove slow signal drifts caused by scanner heating or temporal instability. (8) Temporal filtering: A band-pass filter (0.01–0.08 Hz) was applied to reduce high-frequency physiological noise and low-frequency drifts, retaining the frequency range relevant for spontaneous neural activity. ICA was performed following the steps below: (1) Data preprocessing: Preprocessing was conducted using the Variational Control Group Normalization method. (2) Estimation and decomposition of independent components: The Infomax algorithm was applied to decompose the data into independent components. A total of 32 components were automatically estimated in this study. (3) Principal component analysis (PCA): Standard PCA was used at the individual level, while the Subject-Specific algorithm was applied at the group level to extract principal components. (4) Stability assessment: The ICASSO algorithm was employed to evaluate the stability and reliability of the ICA decomposition. (5)Back-reconstruction: The Spatial–Temporal Regression algorithm was used to back-reconstruct individual-level component maps from the group ICA results. (6)Z-score transformation: The reconstructed component maps were converted into Z-score maps to approximate a normal distribution and facilitate statistical comparison. (7) Component identification: Components with Z-scores ≥ 1 were extracted and subjected to spatial correlation analysis with the Power264 functional atlas. The component showing the highest spatial similarity was identified and used to determine the constituent brain regions of the FPN. GCA computation was conducted as follows: All clusters within the identified brain network were defined as regions of interest (ROIs). For each ROI, a spherical region with a radius of 6 mm was constructed around its central coordinate. The time series of all voxels within each sphere were extracted and averaged to obtain a representative time series for that ROI. Bivariate coefficient GCA was then performed for all ROIs. Each ROI was analyzed in two directions: the causal influence exerted by the ROI on other regions (x → y) and the causal influence imposed by other regions on the ROI (y → x). Pearson correlation coefficients between the mean time series of each pair of ROIs were calculated to generate GCA values, which served as indicators of effective connectivity for subsequent statistical analyses. GCA node degree computation was conducted as follows: To evaluate the centrality of nodes within the network, out-degree, in-degree, and total degree were calculated for each ROI. Out-degree represented the number of directional connections projecting from the node to other nodes, while in-degree represented the number of connections projecting into the node. Total degree was defined as the sum of out-degree and in-degree. Nodes with high in-degree were considered central targets within the network, whereas nodes with high out-degree were regarded as central sources. A node was classified as a core region of the network if its total degree exceeded the mean total degree of all nodes plus one standard deviation. Statistical Analysis Clinical Data Analysis All clinical data were analyzed using SPSS version 26.0. Measurement data were expressed as mean ± standard deviation (χ̄ ± s). For within-group comparisons, paired t-tests were used when variances were homogeneous, and the Wilcoxon signed-rank test was applied when variances were heterogeneous. For between-group comparisons, independent-samples t-tests were used when variances were homogeneous, and the t′-test was applied when variances were unequal. Two-tailed tests were applied throughout, with P < 0.05 considered statistically significant. Rs-fMRI Data Analysis Paired t-tests were used to examine within-group differences in GCA values before and after treatment in both the drug and acupuncture groups. Two-sample t-tests were employed to compare GCA values between AD patients and healthy controls at pre-treatment, as well as between the drug and acupuncture groups after treatment. A voxel-level threshold of P < 0.05 (uncorrected) was considered statistically significant. Due to the relatively small sample size and the exploratory nature of this study, multiple comparison correction was not performed for the fMRI indicators. Results Demographic Characteristics and Cognitive Scale Scores A total of 55 patients with AD were included in the final analysis, comprising 28 participants in the drug group and 27 in the acupuncture group. Prior to treatment, no significant differences were observed between the two groups in age, gender, disease duration, educational level, and MoCA-B scores (P > 0.05; Table 1). Table 1Demographic and Cognitive Characteristics of the Study ParticipantsItemDrug Group (n=28)Acupuncture Group (n=27)StatisticalP valueGender (M/F)10/188/19χ2=0.230.63Age (years)69.21±8.27571.37±7.697t=−1.000.32Disease duration (months)22.21±12.5925.04±10.65t=−0.900.37Education level (years)8.73±3.648.52±3.65t=0.220.83MoCA-B scores13.30±3.1413.50±2.86t=0.250.80 Demographic and Cognitive Characteristics of the Study Participants After treatment, both groups exhibited significant improvements in cognitive performance. In the drug group, MoCA-B scores increased from 13.30 ± 3.14 to 15.71 ± 3.72. Likewise, the acupuncture group demonstrated marked cognitive enhancement, with MoCA-B scores rising from 13.50 ± 2.86 to 16.81 ± 3.89. Notably, post-treatment MoCA-B scores in the acupuncture group were significantly higher than those in the drug group (P < 0.05; Table 2), suggesting that acupuncture provided a superior improvement in global cognitive function. Furthermore, relative to baseline, the mean change in MoCA-B scores after treatment was greater than 2 points in both the drug group and the acupuncture group. Comparison between the two groups revealed a statistically significant difference in the magnitude of change (P < 0.05; Table 3). Table 2Comparison of Cognitive Scores Between the Two Groups at Pre- and Post-TreatmentGroupsMoCA-B ScoresStatisticalP valuePre-TreatmentPost-TreatmentDrug group (n=28)13.30±3.1415.71±3.72t=−9.11<0.001Acupuncture group (n=27)13.50±2.8616.81±3.89t=−17.39<0.001Statisticalt=0.25t=−2.04P value0.800.046 Comparison of Cognitive Scores Between the Two Groups at Pre- and Post-Treatment Table 3Comparison of Changes in MoCA-B Scores Before and After Treatment Between the Two GroupsGroupsMoCA-B ScoresStatisticalP valueDrug group (n=28)2.21±1.29t=−6.63<0.001Acupuncture group (n=27)4.29±1.03 Comparison of Changes in MoCA-B Scores Before and After Treatment Between the Two Groups Neuroimaging results Demographic Data This analysis included 23 patients with AD (12 in the drug group and 11 in the acupuncture group) and 6 age-, gender-, and education-matched healthy controls. Compared with pre-treatment, no significant differences were observed between the two AD groups in age, gender, disease duration, educational level, and MoCA-B scores (P > 0.05; Table 4). Table 4Demographic and Cognitive Characteristics of Study Participants in Neuroimaging AnalysisItemDrug Group (n=12)Acupuncture Group (n=11)StatisticalP valueGender (M/F)3/93/8χ2=0.151Age (years)68.33±6.6769.45±9.40t=−0.330.74Disease duration (months)19.42±9.6228.55±13.20t=−1.910.07Education level (years)7.96±3.6810.64±3.17t=−1.860.07MoCA-B scores14.00±2.8313.37±3.93t=0.190.85 Demographic and Cognitive Characteristics of Study Participants in Neuroimaging Analysis The ICA Analysis results In this study, ICA of the fMRI data from all participants identified the FPN as comprising 14 voxel clusters. The main brain regions included the left cerebellum Crus II; right cerebellum Crus I; right inferior frontal gyrus, orbital part; middle temporal gyrus; middle frontal gyrus; right insula; inferior parietal lobule; left median cingulate and paracingulate gyri; left superior frontal gyrus, medial and the precuneus. The detailed composition of the FPN is presented in Table 5 and illustrated in Figure 3. Table 5Components of the FPNClusterBrain RegionsAALMNI CoordinatesVoxelXYZCluster 1L_Cerebelum_Crus II93−39−72−3924L_Cerebelum_Crus I9126Cluster 2R_Cerebelum_Crus I929−81−27125L_Cerebelum_Crus I9115Cerebelum_Crus II93, 9482R_Cerebelum_610026Vermis_71133R_Cerebelum_7b1021Cluster 3R_ORBinf16156−246R_ORBsup64R_PHG402Cluster 4L_MTG85−63−39−9195L_ITG8993Cluster 5R_MTG8660−45−12143R_ITG9046Cluster 6L_MFG7−4251−3670L_IFGtriang13530L_PreCG1267L_IFGoperc11195L_ORBinf15184L_SFGdor3121L_ORBmid975L_INS2960L_ORBsup527L_PoCG5722L_TPOsup8319L_ROL1713L_SFGmed2310L_HES798L_STG816Cluster 7R_MFG833633618R_IFGtriang14252R_IFGoperc12159R_ORBinf16153R_SFGdor4132R_ORBmid1091R_INS3082R_ORBsup631R_TPOsup8427R_PreCG.215R_ROL187R_SFGmed241Cluster 8R_INS3042−9−99R_STG8211Cluster 9L_IPL61−39−6354508L_ANG65190L_SPG59142L_MOG5151L_PoCG5717L_SOG493L_PCUN672L_SMG631Cluster 10R_IPL6242−5757240R_ANG66178R_SMG64136R_SPG.6097R_PoCG588R_SOG508Cluster 11L_DCG330−333635R_DCG3422R_PCUN682Cluster 12L_SFGmed233274571R_SFGmed248SMA19, 2077Cluster 13R_PCUN689−724850R_SPG602Cluster 14L_PCUN67−6−724819L_SPG591Notes: A cluster refers to a relatively large voxel cluster containing multiple brain regions. Brain regions shown in bold represent the primary regions corresponding to the peak voxel within each cluster, whereas the remaining regions are considered subsidiary regions. AAL denotes the Automated Anatomical Labeling atlas. The peak voxel indicates the location with the most significant effect. MNI refers to the Montreal Neurological Institute coordinate system. The same notation applies to the following tables.Abbreviations: L, left; R, right; ORBinf, Inferior frontal gyrus, orbital part; ORBsup, Frontal_Sup_Orb, Superior frontal gyrus, orbital part; PHG, Parahippocampal gyrus; MTG, Middle temporal gyrus; ITG, Inferior temporal gyrus; MFG, Middle frontal gyrus; FGtriang, Inferior frontal gyrus, triangular part; PreCG, Precentral gyrus; IFGoperc, Inferior frontal gyrus, opercular part; SFGdor, Superior frontal gyrus, dorsolateral; ORBmid, Medial frontal gyrus, orbital part; INS, Insula; PoCG, Postcentral gyrus; TPOsup, Temporal pole (superior temporal gyrus); ROL, Rolandic operculum; SFGmed, Superior frontal gyrus, medial; HES, Heschl gyrus; STG, Superior temporal gyrus; IPL, Inferior parietal lobule (including supramarginal and angular gyri); ANG, Angular gyrus; SPG, Superior parietal gyrus; MOG, Middle occipital gyrus; SOG, Superior occipital gyrus; PCUN, Precuneus; SMG, Supramarginal gyrus; DCG, Median cingulate and paracingulate gyri; SMA, Supplementary motor area. Components of the FPN Notes: A cluster refers to a relatively large voxel cluster containing multiple brain regions. Brain regions shown in bold represent the primary regions corresponding to the peak voxel within each cluster, whereas the remaining regions are considered subsidiary regions. AAL denotes the Automated Anatomical Labeling atlas. The peak voxel indicates the location with the most significant effect. MNI refers to the Montreal Neurological Institute coordinate system. The same notation applies to the following tables. Abbreviations: L, left; R, right; ORBinf, Inferior frontal gyrus, orbital part; ORBsup, Frontal_Sup_Orb, Superior frontal gyrus, orbital part; PHG, Parahippocampal gyrus; MTG, Middle temporal gyrus; ITG, Inferior temporal gyrus; MFG, Middle frontal gyrus; FGtriang, Inferior frontal gyrus, triangular part; PreCG, Precentral gyrus; IFGoperc, Inferior frontal gyrus, opercular part; SFGdor, Superior frontal gyrus, dorsolateral; ORBmid, Medial frontal gyrus, orbital part; INS, Insula; PoCG, Postcentral gyrus; TPOsup, Temporal pole (superior temporal gyrus); ROL, Rolandic operculum; SFGmed, Superior frontal gyrus, medial; HES, Heschl gyrus; STG, Superior temporal gyrus; IPL, Inferior parietal lobule (including supramarginal and angular gyri); ANG, Angular gyrus; SPG, Superior parietal gyrus; MOG, Middle occipital gyrus; SOG, Superior occipital gyrus; PCUN, Precuneus; SMG, Supramarginal gyrus; DCG, Median cingulate and paracingulate gyri; SMA, Supplementary motor area. Three-dimensional representation of the constituent brain regions of the FPN. Note: The spatial map of the FPN was extracted using group-level independent component analysis (ICA) from resting-state fMRI data. The highlighted orange-red regions indicate the key regions of the network. Intra-Group and Inter-Group Comparison of GCA Within the FPN (1) Differences in effective connectivity within the FPN between AD group and HC group Compared with the HC group, patients with AD exhibited a predominant pattern of reduced effective connectivity among ROIs within the FPN, mainly involving parietal and temporal regions. Specifically, significantly decreased GCA values (P < 0.05) were observed in the effective connectivity from the left middle temporal gyrus to the right inferior parietal lobule and the left median cingulate and paracingulate gyri; from the left inferior parietal lobule to the right inferior temporal gyrus and right inferior parietal lobule; from the left medial frontal gyrus, orbital part to the left cerebellum Crus II; from the right inferior parietal lobule to the right cerebellum Crus I; and from the left precuneus to the right insula. In contrast, enhanced effective connectivity was observed in several frontal and temporal regions, including increased GCA values (P < 0.05) from the right inferior frontal gyrus, orbital part and right inferior temporal gyrus to the right superior frontal gyrus, medial; from the right inferior parietal lobule to the left middle temporal gyrus and left medial frontal gyrus, orbital part; and from the left median cingulate and paracingulate gyri to the left middle temporal gyrus (Table 6, Figure 4). Table 6ROI1→ROI2 Connections Within the FPN Showing Significant Differences in GCA Values Between the AD and HC GroupsROI1ROI2T valueP valueBrain RegionsMNIVoxelBrain RegionsMNIVoxelAD group>HC groupR_ORBinf15,6,-2428R_SFGmed3,27,451562.4450.021R_ITG60,-45,-12189R_SFGmed3,27,451562.1050.045R_IPL42,-57,57669L_MTG−63,-39,-92882.6780.012L_DCG0,-33,3659L_MTG−63,-39,-92882.5960.015R_IPL42,-57,57669L_ORBmid−42,51,-322663.0710.005AD groupPre-treatmentL_Cerebelum_Crus II-39,-72,-3950R_PCUN9,-72,48282.5740.0260.74L_DCG0,-33,3659R_SFGmed3,27,451692.6540.0220.77Post-treatmentPre-treatmentL_PCUN−6,-72,4820R_PCUN9,-72,48522.4940.0320.75Post-treatmentDrug groupR_INS42,-9,-922R_Cerebelum_Crus I9,-81,-272522.0970.0480.62R_SFGmed3,27,45156R_Cerebelum_Crus I9,-81,-272522.3980.0260.71R_INS42,-9,-922L_MTG−63,-39,-92882.5060.0210.74L_PCUN−6,-72,4820L_MTG−63,-39,-92882.6840.0140.79Acupuncture group